ARCHIVES

SEC Notifies ImClone It May Bring Action Against Company

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

Letter: Boy Has Little Chance At Cure Without Proven Treatments.

February 11, 2000

Rush-Presbyterian Professor Committed Misconduct, ORI Says

October 6, 1995

Zerhouni to Cancer Researchers: “Stay Calm, Cool” About Funding- And Beware of Myths.

June 16, 2006

OMB Cut $150 Million From NCI Request

March 22, 1974

Clinton R&D Budget Amounts to a Cut, AAAS Study Says

April 18, 1997

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 5, 1974